HSE to breach cost rules to buy new cancer drugs

The HSE is to spend €3.6m a year on new drugs to assist 230 patients with advanced forms of cancer.

HSE to breach cost rules to buy new cancer drugs
Wed, 13 Mar, 2013 - 00:00
Dan Buckley

The decision is in breach of Department of Health cost guidelines but will save or at least prolong lives.

Irish patients will have access to four new cancer drugs this week, following approval by the National Cancer Control Programme (NCCP). The news was welcomed yesterday by the Irish Cancer Society.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

Garda stock Motorcyclist dies following crash in Co Wexford
School classroom scene with kids learning in background Parents call on ministers to address ‘failures’ at special school amid principal abuse claims
Close up of woman receiving botox injection in lips Lack of legislation around injectable aesthetics 'glaring public safety failure'
CourtsPerson: Susan O’ReillyPerson: Gráinne O’RourkeOrganisation: HSEOrganisation: DepartmentOrganisation: National Cancer Control ProgrammeOrganisation: NCCPOrganisation: Irish Cancer SocietyOrganisation: ICS
<p>A Spanish Civil Guard officer inspects the area where passengers from the MV Hondius cruise ship are expected to arrive at the port of Granadilla in Tenerife (Manu Fernandez/AP)</p>

Plans in place to bring Irish passengers on hantavirus-hit ship ship home, officials say

READ NOW

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited